Martin Zweig Detailed Fundamental Analysis

Validea's guru fundamental report indicates that Charles Schwab (SCHW) receives a 77% rating based on their Growth Investor model, which is based on the investment strategy of Martin Zweig. The model favors SCHW due to its persistent accelerating earnings and sales growth, reasonable valuation, and low debt; however, the stock fails certain criteria related to sales growth, earnings persistence and long-term EPS growth.

Analysis

Charles Schwab Corp (SCHW) scores 77% according to Validea's Growth Investor model, based on Martin Zweig's strategy, which seeks growth stocks with accelerating earnings and sales, reasonable valuations, and low debt. This rating is proximate to, but below, the 80% threshold that typically signals model interest. SCHW demonstrates strengths by passing criteria related to its P/E ratio, revenue growth in relation to EPS growth, current quarter earnings, positive earnings growth rate for the current quarter, and earnings growth over the past several quarters. Furthermore, its current quarter EPS growth exceeds that of the prior three quarters and its historical growth rate, and insider transactions are favorable. Conversely, the model identifies weaknesses as SCHW fails tests for sales growth rate, earnings persistence, and long-term EPS growth, indicating potential headwinds in sustaining top-line expansion and consistent long-term earnings progression despite current positive momentum.

Key Decisions for Investors

• Investors should consider the mixed signals, weighing SCHW's positive current earnings metrics, reasonable valuation, and favorable insider transactions against notable model failures in sales growth rate, earnings persistence, and long-term EPS growth.
• Given the 77% score is just shy of the model's typical interest level, diligent monitoring of future earnings reports for improvements in sales growth and commentary on long-term earnings sustainability is advised.
• For investors focused specifically on sustained high growth, the identified weaknesses in sales growth and long-term EPS growth warrant careful consideration, potentially tempering enthusiasm despite other positive indicators.